Table 2 Treatment response at 1 year after ITP diagnosis and medications used during treatment
Total (n = 130) | No SLE (n = 120) | SLE (n = 10) | P value | |
|---|---|---|---|---|
Treatment response | 1.00 | |||
Complete | 54 (41.5) | 50 (41.7) | 4 (40.0) | |
Partial | 47 (36.2) | 43 (35.8) | 4 (40.0) | |
No response | 29 (22.3) | 27 (22.5) | 2 (20.0) | |
Medications | ||||
First-line treatments | ||||
Corticosteroid use more than 1 month | 108 (83.1) | 99 (82.5) | 9 (90.0) | 1.00 |
Intravenous immune globulin | 30 (23.1) | 28 (23.3) | 2 (20.0) | 1.00 |
Anti-Rho(D) antibody | 5 (3.8) | 4 (3.3) | 1 (10.0) | 0.33 |
Second-line treatments | ||||
Rituximab | 2 (1.5) | 2 (1.7) | 0 | 1.00 |
Romiplostim | 1 (0.8) | 1 (0.8) | 0 | 1.00 |
Eltrombopag | 4 (3.1) | 4 (3.3) | 0 | 1.00 |
Splenectomy | 14 (10.8) | 13 (10.8) | 1 (10.0) | 1.00 |
Other treatments | ||||
Azathioprine | 11 (8.5) | 9 (7.5) | 2 (20.0) | 0.20 |
Cyclosporine | 2 (1.5) | 2 (1.7) | 0 | 1.00 |
Danazole | 31 (23.8) | 30 (25.0) | 1 (10.0) | 0.45 |
Oxymetholone | 1 (0.8) | 1 (0.8) | 0 | 1.00 |
Helicobacter pylori eradication | 18 (13.8) | 17 (14.2) | 1 (10.0) | 1.00 |